.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Colorcon
Queensland Health
QuintilesIMS
Medtronic
AstraZeneca
Chinese Patent Office
Cerilliant
Argus Health
Moodys

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,387,103

« Back to Dashboard

Summary for Patent: 4,387,103

Title: Method for treatment or prophylaxis of cardiac disorders
Abstract:A method for the treatment of prophylaxis of cardiac disorders in a mammal, comprising administering to such mammal a short-acting .beta.-blocking compound of the formula: ##STR1## wherein R may be lower alkyl, aryl, or aralkyl; n may be an integer from 0 to about 10; x may be an integer from 1 to 3; Ar may be substituted or unsubstituted aromatic; R.sub.1 may be lower alkyl, or aralkyl; and pharmaceutically accepted salts thereof. Novel compounds possessing short-acting .beta.-adrenergic blocking activity are also disclosed.
Inventor(s): Erhardt; Paul W. (Mundelein, IL), Borgman; Robert J. (Mundelein, IL), O'Donnell; John P. (Morgantown, WV)
Assignee: American Hospital Supply Corporation (Evanston, IL)
Application Number:06/211,345
Patent Claim Types:
see list of patent claims
Use;

No matches for this query

International Patent Family for Patent: 4,387,103

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria20878► Subscribe
Australia546424► Subscribe
Australia7893881► Subscribe
Canada1258868► Subscribe
Germany3174993► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Citi
Accenture
Baxter
US Army
QuintilesIMS
Cantor Fitzgerald
Fish and Richardson
Boehringer Ingelheim
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot